Dr Steptoe’s research interests are aimed at determining the cellular and molecular pathways that are important in determining the fate of T-cell activation. In particular, studies are directed at understanding how to terminate pathogenic T cell responses with the goal of developing new therapeutic approaches to prevent or treat autoimmune diseases.
Dr Ray Steptoe undertook undergraduate studies in Anatomy and Human Biology and postgraduate studies in Immunology at the University of Western Australia. After further research training at the Thomas E. Starzl Transplantation Institute in Pittsburgh, USA, he returned to Australia to pursue research in autoimmune diabetes at the Walter and Eliza Hall Institute of Medical Research. In 2004, he moved to Brisbane to take up a Research Fellowship in the Immunology Program at the Diamantina Institute.
Dr Steptoe is now a Senior Research Fellow in the Dendritic Cell Biology group and heads a team of researchers investigating how pathogenic immune responses can be turned off. Dr Steptoe is currently a recipient of an NH&MRC Career Development Award.